These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 27742835)
21. Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907. Fritsche L; Neukamm SS; Lehmann R; Kremmer E; Hennige AM; Hunder-Gugel A; Schenk M; Häring HU; Schleicher ED; Weigert C Am J Physiol Endocrinol Metab; 2011 May; 300(5):E824-36. PubMed ID: 21098738 [TBL] [Abstract][Full Text] [Related]
23. Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor. Wick KR; Werner ED; Langlais P; Ramos FJ; Dong LQ; Shoelson SE; Liu F J Biol Chem; 2003 Mar; 278(10):8460-7. PubMed ID: 12493740 [TBL] [Abstract][Full Text] [Related]
24. Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth. Hsia HE; Kumar R; Luca R; Takeda M; Courchet J; Nakashima J; Wu S; Goebbels S; An W; Eickholt BJ; Polleux F; Rotin D; Wu H; Rossner MJ; Bagni C; Rhee JS; Brose N; Kawabe H Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13205-10. PubMed ID: 25157163 [TBL] [Abstract][Full Text] [Related]
25. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Yu Y; Yoon SO; Poulogiannis G; Yang Q; Ma XM; Villén J; Kubica N; Hoffman GR; Cantley LC; Gygi SP; Blenis J Science; 2011 Jun; 332(6035):1322-6. PubMed ID: 21659605 [TBL] [Abstract][Full Text] [Related]
26. Molecular brakes regulating mTORC1 activation in skeletal muscle following synergist ablation. Hamilton DL; Philp A; MacKenzie MG; Patton A; Towler MC; Gallagher IJ; Bodine SC; Baar K Am J Physiol Endocrinol Metab; 2014 Aug; 307(4):E365-73. PubMed ID: 24961241 [TBL] [Abstract][Full Text] [Related]
27. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463 [TBL] [Abstract][Full Text] [Related]
28. Mammalian target of rapamycin and p70S6K mediate thrombin-induced nuclear factor-κB activation and IL-8/CXCL8 release in human lung epithelial cells. Lin CH; Shih CH; Jiang CP; Wen HC; Cheng WH; Chen BC Eur J Pharmacol; 2020 Feb; 868():172879. PubMed ID: 31863766 [TBL] [Abstract][Full Text] [Related]
29. Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling. Scheufele F; Wolf B; Kruse M; Hartmann T; Lempart J; Mühlich S; Pfeiffer AFH; Field LJ; Charron MJ; Pan ZQ; Engelhardt S; Sarikas A Cell Signal; 2014 Feb; 26(2):233-239. PubMed ID: 24219910 [TBL] [Abstract][Full Text] [Related]
30. Adenosine 5'-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages. Zhu YP; Brown JR; Sag D; Zhang L; Suttles J J Immunol; 2015 Jan; 194(2):584-94. PubMed ID: 25512602 [TBL] [Abstract][Full Text] [Related]
31. Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR. Tzatsos A J Biol Chem; 2009 Aug; 284(34):22525-34. PubMed ID: 19561084 [TBL] [Abstract][Full Text] [Related]
32. Ubiquitin ligase Nedd4-2 modulates Kv1.3 current amplitude and ion channel protein targeting. Vélez P; Schwartz AB; Iyer SR; Warrington A; Fadool DA J Neurophysiol; 2016 Aug; 116(2):671-85. PubMed ID: 27146988 [TBL] [Abstract][Full Text] [Related]
34. Low-frequency electroacupuncture improves disordered hepatic energy metabolism in insulin-resistant Zucker diabetic fatty rats via the AMPK/mTORC1/p70S6K signaling pathway. Liu XX; Zhang LZ; Zhang HH; Lai LF; Wang YQ; Sun J; Xu NG; Li ZX Acupunct Med; 2022 Aug; 40(4):360-368. PubMed ID: 35034504 [TBL] [Abstract][Full Text] [Related]
35. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
36. IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View. Keegan AD; Zamorano J; Keselman A; Heller NM Front Immunol; 2018; 9():1037. PubMed ID: 29868002 [TBL] [Abstract][Full Text] [Related]
37. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle. Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856 [TBL] [Abstract][Full Text] [Related]
38. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. Greene MW; Sakaue H; Wang L; Alessi DR; Roth RA J Biol Chem; 2003 Mar; 278(10):8199-211. PubMed ID: 12510059 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. Bose SK; Shrivastava S; Meyer K; Ray RB; Ray R J Virol; 2012 Jun; 86(11):6315-22. PubMed ID: 22457523 [TBL] [Abstract][Full Text] [Related]